JOHNSON & JOHNSON

Trading Ideas Johnson & Johnson Santiago S.E.

Equities

JNJ

US4781601046

Real-time Estimate Cboe BZX Other stock markets 20:00:00 2024-06-28 EDT			5-day change	1st Jan Change
146.4 ^USD	-1.29%		0.00%	-6.76%

06-28	Johnson & Johnson Reports 'Positive' Results in Late-Stage Myasthenia Gravis Trial	MT
06-28	J&J Unit's Rybrevant Combo Gets EU Approval	MT

Trading Ideas

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

JOHNSON & JOHNSON :An end to the technical rebound lies ahead	19-11-27
JOHNSON & JOHNSON :The underlying trend is to the upside	17-06-12
JOHNSON & JOHNSON :Expect the comeback of a strong trend	17-05-10
JOHNSON & JOHNSON :Buying pressure	16-12-22
JOHNSON & JOHNSON :A good level to buy	16-09-12
JOHNSON & JOHNSON :Towards historic highs	12-09-26
JOHNSON & JOHNSON :Beginning of a bearish movement	12-06-26

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 12:30 pm

Protect and grow your investments with the help of our experts

Securing my Investments

fermer